Helena Andrade-De

Av. Professor Gama Pinto
Lisbon, 1649003, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Dengue Virus NS5 Target Discovery: A Comprehensive in Silico Exploration of Novel Druggable Sites for Pan-Serotype Antiviral Design.

Dengue Virus NS5 Target Discovery: A Comprehensive in Silico Exploration of Novel Druggable Sites for Pan-Serotype Antiviral Design.

Journal: International journal of molecular sciences
Published: April 10, 2026

The RNA-Binding Domain NS1 of Influenza as an Antiviral Target: From Evolutionary Conservation Mapping to Experimental Validation.

The RNA-Binding Domain NS1 of Influenza as an Antiviral Target: From Evolutionary Conservation Mapping to Experimental Validation.

Journal: Viruses
Published: January 16, 2026

Adaptive evolution of PB1 from influenza A(H1N1)pdm09 virus towards an enhanced fitness.

Adaptive evolution of PB1 from influenza A(H1N1)pdm09 virus towards an enhanced fitness.

Journal: Virology
Published: September 15, 2022

Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerases.

Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerases.

Journal: Virology
Published: July 03, 2022

Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2.

Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2.

Journal: Pharmaceutics
Published: February 24, 2022

Optimization of A(H1N1)pdm09 vaccine seed viruses: The source of PB1 and HA vRNA as a major determinant for antigen yield.

Optimization of A(H1N1)pdm09 vaccine seed viruses: The source of PB1 and HA vRNA as a major determinant for antigen yield.

Journal: Virus research
Published: January 10, 2022

COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity.

COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity.

Journal: Immunogenetics
Published: January 10, 2022

NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication.

NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication.

Journal: Virology
Published: September 08, 2021

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.

Journal: Computational and structural biotechnology journal
Published: June 04, 2020

To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential.

To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential.

Journal: Virology
Published: February 19, 2019

The 1918-1919 Influenza Pandemic in Portugal: A Regional Analysis of Death Impact.

The 1918-1919 Influenza Pandemic in Portugal: A Regional Analysis of Death Impact.

Journal: American journal of epidemiology
Published: April 13, 2018

Molecular footprints of selective pressure in the neuraminidase gene of currently circulating human influenza subtypes and lineages.

Molecular footprints of selective pressure in the neuraminidase gene of currently circulating human influenza subtypes and lineages.

Journal: Virology
Published: November 17, 2017
Showing 1-12 of 23

Last Updated: 09/26/2026